approach
precise analysis. tailored approach
We begin by analyzing your project to pinpoint the exact requirements, then tailor our support to your goals, timeline, and budget. Our solutions-driven approach addresses your unique challenges with expertise and efficiency. Successful projects thrive on detailed planning that adapts dynamically, driving towards milestones aligned to meaningful value-inflection points. We ensure focus on execution and measurable results at every milestone. Robust analysis helps to de-risk development early and uncovers additional opportunities for value creation.
What does stage-appropriate development look like?
- Early clinical development
CMC is almost always on the critical path for starting Phase 1. Avoid overdeveloping your product at this stage: limit changes to API syntheses and use a simple formulation with limited stability, sufficient for your study needs. Address IMPD gaps efficiently during regulatory review rather than re-engineering the entire program upfront.
- Late-stage / exit preparation
A Phase 3-ready asset is critical for valuations at exit. Demonstrate reliability and robustness of your supply chain, and ensure sufficient product for clinical supply. Your goal is a program that allows a buyer to “hit the ground running” on pivotal studies, with no major CMC or supply surprises
more than consultants. true partners
more than consultants. true partners.
We adapt our support to your needs, delivering exactly the expertise required — whether for a specific milestone or long-term strategic guidance. Our engagement can be focused and short-term but most clients benefit from sustained and hands-on partnership. We grow with your company, support investor and partner discussions, and guide critical decisions across CMC, regulatory, and clinical development. We act as true partners, not outside observers.
What are fractional resources?
- “Part of a person” rather than “part of the job”
You engage a senior specialist on a part-time or retained basis instead of hiring full-time. You get a fraction of their time but can still expect full accountability for the scope they own. Time commitment can be flexible, enabling future scale-up or scale-down.
- Embedded expert
You get direct access to deep technical knowledge and hands-on leadership within your team. Seasoned professionals operate as if they were internal, driving results without the overhead of permanent staff.
effective network. real connections.
We build strong connections across the global biotech community. We work with manufacturers, regulators, and pharma companies internationally. You get access to a pool of seasoned experts in our network. Meet us at industry and pitch events, looking out for latest trends and new players.
Just want to talk? Schedule a meeting.
- Free CMC check-up
You receive a high-level assessment of your current CMC roadmap in a 30-min meeting to identify gaps and risks and discuss potential challenges.
- Mentoring
We provide strategic direction to academic researchers and pre-seed biotech founders to prepare for grant applications or investor discussions. Develop your own business canvas.